Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allarity Acquisition Corp. is a newly organized blank check company (SPAC) incorporated in the Cayman Islands and backed by Allarity Therapeutics. The company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. While it may pursue an initial business combination in any industry, sector, or geographic region, it intends to focus its search on the life sciences and biotechnology sectors. The company is sponsored by ALLR Sponsor LLC, a wholly-owned subsidiary of Allarity Therapeutics, and is led by CEO Thomas Jensen and Chairman Jesper Hoiland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allarity Acquisition.